Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Systematic review for the development of a pharmaceutical and medical products prioritization framework.

Frutos Pérez-Surio A, Gimeno-Gracia M, Alcácera López MA, Sagredo Samanes MA, Pardo Jario MDP, Salvador Gómez MDT.

J Pharm Policy Pract. 2019 Aug 21;12:21. doi: 10.1186/s40545-019-0181-2. eCollection 2019.

2.

[Incorporation of the hospital pharmacist into the project "Commitment to quality of the Spanish scientific societies"].

Frutos Pérez-Surio A, Allende-Bandrés MÁ, Puértolas-Tena I, Arenere-Mendoza M.

Farm Hosp. 2018 Jan 1;42(1):37-39. doi: 10.7399/fh.10911. Spanish. No abstract available.

3.

Effectiveness of biosimilar filgrastim vs. original granulocyte colony-stimulating factors in febrile neutropenia prevention in breast cancer patients.

Puértolas I, Frutos Pérez-Surio A, Alcácera MA, Andrés R, Salvador MDT.

Eur J Clin Pharmacol. 2018 Mar;74(3):315-321. doi: 10.1007/s00228-017-2365-5. Epub 2017 Nov 19.

PMID:
29152672
4.

Evidence-based medicine clinical practice guidelines in the Spanish National Health System.

Frutos Pérez-Surio A, Sala-Piñol F, Sanmartí-Martinez N.

Eur J Hosp Pharm. 2016 Nov;23(6):308-313. doi: 10.1136/ejhpharm-2015-000836. Epub 2016 Feb 26.

5.

Sumario de recomendaciones nutricionales basadas en la evidencia de la Guía de Prácti ca Clínica para el manejo de pacientes con enfermedad de Parkinson.

Baladia E, Frutos Pérez-Surio A, Martínez-Rodríguez R.

Nutr Hosp. 2016 Jun 30;33(3):287. doi: 10.20960/nh.287. Review. Spanish.

6.

[Prevalence of antiparkinsonian treatment complications: a systematic review and estimation of projections].

Fernández-Sanchis D, Frutos Pérez-Surio AF, López del Val LJ.

Rev Neurol. 2015 Aug 1;61(3):97-105. Review. Spanish.

Supplemental Content

Loading ...
Support Center